Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
The FDA approved a 900-unit insulin glargine pen, the highest capacity long-acting insulin pen on the market in the U.S., Sanofi announced in a press release. The new insulin glargine (Toujeo) Max ...
Sanofi (Euronext: SAN; NYSE: SNY) announced today that it received FDA approval for its Toujeo Max SoloStar insulin pen, the highest capacity long-acting insulin pen that will be available on the ...
Sanofi-Aventis US is rolling out a consumer campaign for its Lantus SoloStar pen aimed at getting people with type 2 diabetes to think differently about insulin. Dubbed “I Chose,” the effort is ...
PALO ALTO, Calif., Feb. 23, 2023 /PRNewswire/ -- Glooko Inc. ("Glooko"), today announced that they have entered into a partnering agreement with Sanofi to increase their support of people living with ...
In December 2016, Zealand received the $ 25 million milestone payment triggered by the FDA approval of Soliqua 100/33 Copenhagen, 4 January 2017 - Zealand Pharma (Zealand) reports that Sanofi ...
∙ As a first result of the exclusive negotiations initiated in July, the two companies sign a global distribution agreement ∙ After an initial payment of €4 million, BIOCORP receives a new payment of ...
The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results